RecallRadar

FDA Drug recall D-0550-2026

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorp…

On 2026-06-03 the FDA classified a Class III recall of Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorp… by Aveva Drug Delivery Systems, citing failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0550-2026
ClassificationClass III
Statusongoing
Initiated2026-05-14
Published2026-06-03
Last updated2026-09-13 11:52 UTC
CompanyAveva Drug Delivery Systems
DistributionUS

Product

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Reason

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Identifiers

ndc0536-5896-53
ndc0536-5896-88
ndc0536-5896-71
ndc0536-5895-53
ndc0536-5895-88
ndc0536-5895-71
ndc0536-5894-53
ndc0536-5894-88
code_infoLot #: 56841, Expires: 03/2028

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0550-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.